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Abstract
Purpose Fractal analysis can be used to quantitatively analyze the retinal microvasculature and might be a suitable method to
quantify retinal capillary changes in sickle cell disease (SCD) patients. Retinal oximetry measurements might function as a proxy
for the pathophysiology of cerebrovascular diseases. Moreover, hypoxia has an important role in the pathophysiology of diabetic
and other retinopathies. However, little is known about the oximetry around the macula in SCD patients. With this study, we
explored the feasibility to perform these quantified measurements in SCD patients.
Methods Retinal microvascular and oximetry measurements were performed in eight SCD patients and eight healthy matched
controls. Oximetry pictures and non-invasive capillary perfusion maps (nCPM) were obtained by the retinal function imager.
Measurements were conducted twice on two different study days. Measured variables included monofractal dimension (Dbox),
relative saturation, deoxygenated hemoglobin (deoxyHb), and oxygenated hemoglobin (oxyHb) concentration.
Results No statistically significant differences in vessel density were found in the different annular zones (large vessels, p = 0.66;
small vessels, p = 0.66) and anatomical quadrants (large vessels, p = 0.74; small vessels, p = 0.72). Furthermore, no significant
between-group differences were found in the other different anatomical quadrants and annular zones around the fovea for relative
saturation levels and deoxygenated Hb. However, the oxyHb levels were significantly lower in SCD patients, compared with
those in matched controls in the temporal quadrants (p = 0.04; p = 0.02) and the superior nasal quadrant (p = 0.05).
Conclusions Our study demonstrated the feasibility of multispectral imaging to measure retinal changes in oxygenation in both
SCD patients and matched volunteers. The results suggest that in SCD patients before any structural microvascular changes in the
central retina are present, functional abnormalities can be observed with abnormal oximetry measurements.
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Introduction
Sickle cell disease (SCD) is the most common inherited blood
disorder in Europe and worldwide [1, 2]. Because of increas-
ing immigration rates from Northern and sub-Saharan regions
of Africa, SCD should be acknowledged as a major public
health issue worldwide [3]. SCD is characterized by structural
defects of the hemoglobinmolecule, leading to acute or chron-
ic anemia and vaso-occlusive crisis (VOC), which can lead to
hospitalization and severe organ damage. Several organs
might be affected including the kidneys, lungs, cerebrovascu-
lar damage, bones, and the retina [4]. In general, SCD is an
inherited disease which may manifest itself already at early
childhood. Due to chronicity of the disorder, patients may
have intermittent live long symptoms and progressive organ
failure due to multiple crises and insufficient oxygen
perfusion.
Although SCD mostly manifests peripherally in the retina
[5], structural and functional abnormalities in the retinal vas-
culature around the macula have been observed. [6, 7] Insights
in these retinal microvascular changes allows for optimal di-
agnosis and treatment of SCD patients. The retina is known
for its high demand for oxygen and might therefore function
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as a proxy for the pathophysiology of cerebrovascular dis-
eases in general, but also for SCD.
Retinal oximetry is a non-invasive imaging technique
wherein fundus photography is combined with the use of mul-
tispectral filters to determine oxygen saturation in the retinal
blood vessels [8]. As abnormal retinal saturation plays an
important role in the pathophysiology of retinopathies in sev-
eral conditions [9], retinal oximetry imaging has been applied
in several patient groups over the past decades [10, 11].
Information about the retinal microvasculature can be obtain-
ed through the analysis of non-invasive capillary perfusion
maps (nCPM) by means of fractal analysis. Fractal analysis
provides a global index that quantifies the geometric complex-
ity of the retinal vascular network, summarizing the entire
branching pattern, and may be a more sensitive indicator of
early microvascular disease compared with overt retinopathy
signs [12]. This method has been applied in patients with
Diabetes Mellitus [13], Multiple Sclerosis [14], and high my-
opia [15].
Until now, knowledge about oximetry in retinal tissue
around the macula in SCD patients is scarce. Oximetry images
and nCPM can be obtained by the retinal function imager
(RFI). Previous studies performed with the RFI were only able
to perform a qualitative analysis of the oximetry status of the
retina [10], whereas quantitative analysis can be more infor-
mative about the retinal status. The current study was the first
to quantify retinal oximetry measurements obtained by the
RFI in SCD patients and matched controls. With this study,
we aimed to qualify newRFI-derived quantitativemeasures of
retinal dysfunction in SCD.
Material and methods
Study population
Details about the study population, study design, outcome
measures, and assessments were extensively described in the
study protocol by Birkhoff et al. [7] In brief, retinal measure-
ments were performed in SCD patients (self-reported) (n = 8)
aged 18–65 years and healthy controls matched for age, eth-
nicity, gender, and body mass index (n = 8 for capillary maps
imaging and n = 9 for oximetry measurements). SCD patients
were recruited through advertisements in local papers or by
referral from their treating specialist.
Study design
This was an observational study conducted at the Centre for
Human Drug Research (CHDR) in Leiden, the Netherlands.
RFI was conducted twice on two study days separated by
1 week. The study protocol was approved by the ethics
committee of Leiden University and performed according to
the Dutch law on medical research.
Retinal capillary maps imaging
Retinal microcirculation was quantified using the RFI 3005
(Optical Imaging, Rehovot, Israel). Measurements were per-
formed as described in the study protocol [7]. In brief, one
pupil was dilated using tropicamide. The subject remained
seated quietly with the head in a headrest, which allowed for
the collection of 10–15 series of eight retinal images in 20
degrees field of view over a period of 25 min. Of the eight
images per subject, eight were used for fractal analysis of the
nCPM. The images were initially edited and exported using
Odian browse software (Optical Imaging, Rehovot, Israel).
Subsequently, the best image series for each subject was man-
ually selected based on the image quality (i.e., brightness and
sharpness) and consequently analyzed.
Image processing
Fractal analysis of the nCPMs obtained by the RFI was per-
formed with an automated Matlab (The Mathworks, Inc.,
Natick, MA, USA) script, which was described elsewhere
[12]. In brief, acquired capillary maps were processed to sep-
arate microvessels from the original image. Subsequently,
box-counting fractal analysis was performed on the processed
images. Endpoints were defined as vessel density (Dbox) in
different annular and quadrantal zones, which represents the
counted small and large vessels at the capillary map. Figure 1
demonstrates the image processing of nCPMs.
Retinal oximetry
Retinal oximetry maps were acquired with use of the RFI by
making series of eight retinal images in a field of view of 35
degrees, using a fast filter wheel with four different wave-
lengths, of which two oxygen-insensitive (548 nm and
586 nm) and two oxygen-sensitive (575 nm and 600 nm)
wavelengths. The eight images were aligned and were ac-
quired at 55–100 Hz. Each series contained two images of
four different wavelengths. Dark reference images, captured
by keeping the camera shutter closed, were used to correct for
non-uniformity. Due to the lack of a reference standard, only
relative oxygenation could be calculated. To normalize the
images taken at the oxygen-sensitive wavelengths, we used
the images taken at isosbestic points, i.e., a specific wave-
length, at which the total absorbance of light of the oxygenat-
ed and deoxygenated Hb is equal (Fig. 2). The images taken at
600 nm were corrected with use of the images taken at
586 nm, thereby creating an image with deoxygenated Hb
(deoxyrel = I600nm / I586nm). The images taken at 575 nm were
normalized with use of the images taken at 548 nm, thereby
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creating an image with oxygenated Hb (oxyrel = I575nm /
I548nm). Consequently, according to the modified Beer-
Lambert law, a relative saturation map could be computed
(SO2 rel = − log (oxyrel / oxyrel + deoxyrel) [16]. This relative
saturation map was converted into a color-basedmap, to make
interpretation of saturation easier (blue, low saturation; red,
high saturation). For the analysis of the oximetry intensi-
ties, the best series were manualy chosen for each subject.
We selected several regions of interest (ROIs), which
were analyzed with use of MeVisLab, version 3.1
(MeVis Medical Solutions AG and Fraunhofer MEVIS,
Germany). Circles were drawn showing four different di-
ameters (10 mm, 25 mm, 50 mm, and 75 mm) around the
macula. Four quadrants (superior nasal, inferior nasal, su-
perior temporal, and inferior temporal) were defined. The
side of each square, i.e., the size of the quadrants, was
determined by taking the distance from the optic disk to
the central part of the fovea. Outcomes indicative for the
relative oxygen density were expressed per deoxygenated
Hb and oxygenated Hb in arbitrary units (AU) and mul-
tiplied by 10,000 because the analysis in our software
(i.e., calculations based on histograms) required integer
values. Saturation was calculated from deoxygenated Hb
and oxygenated Hb according to the modified Beer-
Lambert law (Fig. 2).
Statistical analysis
For repeatedly assessed endpoints (Dbox) of the capillary
maps, contrasts between groups were estimated with a mixed
model analysis of variance with fixed factors group (SCD
patients and matched healthy subjects), day (day 1 and day
8), measurement (0 and 2 h), group by day, group bymeasure-
ment and group by day by measurement, and subject, subject
by day and subject by time as random factors. By using the
same subject ID for the matched subjects, comparisons were
pairwise. In both groups, the intra subject variability was
Fig. 1 A non-invasive capillary
perfusion map (nCPM) (a) proc-
essed into an acquired capillary
map (b) for box-counting fractal
analysis of vessel density
Fig. 2 Schematic overview of oximetry measurements. Schematic
overview of oximetry measurements. (1) Images were taken using a fast
filter wheel with four different wavelengths, of which two oxygen-
insensitive (548 nm and 586 nm) and two oxygen-sensitive (575 nm
and 600 nm) wavelengths. (2) The images from oxygen-sensitive
wavelengthswere normalized with images from isosbestic points, thereby
creating (de)oxygenated images. (3) According to the modified Beer-
Lambert law, a relative saturation map was computed, of which different
regions where analyzed
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calculated for Dbox, from the estimated variabilities within
the statistical model.
For oxygenation determination, overall intensities (includ-
ing minimum, maximum, mean, median, interquartile range
(IQR) 25–75, peak intensity, and standard deviation) were
calculated for each ROI. Each parameter was analyzed using
a unpaired Student’s t test comparing SCD patients and
matched controls; p values < 0.05were considered statistically
significant. For oxygenation maps, the minimal detectable ef-
fect size (MDES) was calculated, assuming a parallel compar-
ison of two groups of eight subjects. All calculations were
performed using SAS for windows V9.4 (SAS Institute,
Inc., Cary, NC, USA).
Results
Study population
Subject characteristics are summarized in Table 1. All includ-
ed subjects were female.
Of all SCD patients, six had homozygous SCD (HbSS) and
one heterozygous SCD (HbSE). One subject was uncertain
about the SCD subtype. Patients received diverse medica-
ments, including folic acid, hydroxycarbamide, vitamin D,
deferasirox, deferiprone, and acetaminophen. One SCD pa-
tient was on hydroxyurea therapy.
Capillary maps
Figure 3 summarizes the results from the fractal dimension
analysis in SCD patients and matched controls, which was
performed in the different anatomical quadrants and annular
zones around the fovea. We found no significant difference
between the SCD patients and the matched controls group
with respect to vessel density (Dbox) in large vessels (estimate
of the difference, 0.0096; 95%CI − 0.0376, 0.0568; p = 0.66)
and small vessels (estimate of the difference 0.0033; 95%CI −
0.0146, 0.0212; p = 0.69) in the different annular zones
around the fovea. In addition, we found no significant
between-group difference with respect to vessel density in
the different anatomical quadrants of large vessels (estimate
of the difference 0.0086; 95%CI − 0.0488, 0.0659; p = 0.74)
and small vessels (estimate of the difference 0.0188; 95%CI −
0.1299, 0.0923; p = 0.72).
Oximetry maps
We found no significant between-group difference in the dif-
ferent anatomical quadrants and annular zones around the fo-
vea with respect to relative saturation levels and deoxygenated
Hb. Oxygenated Hb levels were significantly lower in SCD
patients compared with those in matched controls in the tem-
poral quadrant 2 (effect size (ES) = 850.3; 95%CI 69.16,
1631; p = 0.04), temporal quadrant 3 (ES = 919.9; 95%CI
Table 1 Demographics
SCD patients (n = 8) Matched controls (n = 8)
Age (years) 34 ± 7.5 31 ± 7.6
BMI kg/m2 25.4 ± 4.8 26.4 ± 4.2
Male:female 0:8 0:8
Systolic blood pressure (mmHg) 109 ± 8 116 ± 18
Diastolic blood pressure (mmHg) 65 ± 6 73 ± 12
Demographics obtained during the first occasion for capillary maps measurements. Vital signs were acquired
before any measurement had taken place, in both occasions
Fig. 3 Vessel density expressed
in Dbox values for all vessels (a),
small vessels in different
quadrantal zones (b), and annular
zones (c) image processing of
nCPMs
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171.4, 1668; p = 0.02), and the superior nasal quadrant 1
(ES = 763.8; 95%CI 16.03, 1512; p = 0.05). Table 2 provides
an overview of all retinal oximetry outcomes in different
quadrants and annular zones.
Variability and minimal detectable effect size
Intra subject variability was small for most capillary map mea-
surements, with a coefficient of variation (CV) < 10%. Based
upon a parallel comparison of the two groups of eight subjects,
the calculated MDES for oximetry measurements in the retina
were 173 AU for saturation maps; 198 AU for oxygenated Hb
maps, and 530 AU for deoxygenated Hb maps.
Discussion
In this study, we explored the performance of the RFI to study
retinal oximetry measurements and to quantify capillary maps
in SCD patients and matched healthy controls. A significant
difference was observed for oxygenated Hb maps in the peri-
foveal quadrants. Oxygenated Hb levels were significantly
lower in SCD patients compared with those in matched con-
trols. We found no significant difference in vessel density,
saturation, and deoxygenated Hb maps between SCD patients
and matched controls in all anatomical quadrants and annular
zones.
RFI is a validated methodology that was designed to direct-
ly and non-invasively image the capillary network of the ret-
ina in great detail. RFI has been able to measure functional
microvascular abnormalities in different patient groups, in-
cluding SCD patients [7]. Furthermore, several studies have
demonstrated the validity of fractal analysis of nCPM in dif-
ferent patients groups as multiple sclerosis patients and sub-
jects with high myopia [15, 17]. Our results, showing a low
intra subject variability for most nCPM endpoints, support
these findings.
Although previous studies using optical coherence
tomography-angiography (OCT-A) in SCD patients found an-
atomical differences in capillary structure [6, 18], we were not
able to repeat these results. This might be due to the fact that
the sickle cell patients included in this study were relative
Table 2 Oxygen density measures in different quadrants and annular zones
SCD patients (n = 8) Matched
controls (n = 9)
Effect size controls VS SCD patients p value
Annular zone 10 mm
around the fovea
Saturation 2212 (210) 2191 (330) − 20.52 (95%CI: − 328.5; 287.4) 0.89
Deoxygenated Hb 4609 (400) 4738 (692.4) 128.6(95%CI − 503.9; 761.2) 0.67
Oxygenated Hb 18,670 (958) 19,380 (595) 710.1 (95%CI − 124.0; 1544) 0.09
Annular zone 25 mm
around the fovea
Saturation 2170 (189) 2130 (317) − 40.54(95%CI − 331.6; 250.5) 0.77
Deoxygenated Hb 4561 (362) 4749 (708) 188.3(95%CI − 444.3; 820.9) 0.53
Oxygenated Hb 18,872 (995) 19,575 (606) 702.8 (95%CI − 157.6; 1563) 0.10
Annular zone 50 mm
around the fovea
Saturation 2170 (153) 2102 (292) − 68.14 (95%CI − 330.0; 193.7) 0.59
Deoxygenated Hb 4579 (310) 4577 (609) − 1.937(95%CI − 45.4; 541.6) 0.99
Oxygenated Hb 18,940 (933) 19,605 (658) 665.1(95%CI − 186.3; 1517) 0.12
Annular zone 75 mm
around the fovea
Saturation 2213 (133) 2127 (284) − 89.19(95%CI − 336.3; 164.0) 0.47
Deoxygenated Hb 4638 (292) 4610 (594) − 27.63(95%CI − 555.0; 499.7) 0.91
Oxygenated Hb 18,773 (861) 19,493 (668) 719.7 (95%CI − 98.17; 1538) 0.08
Quadrant 1: nasal superior Saturation 2381 (168) 2197 (280) − 183.1 (95%CI; 440.5–74.24) 0.15
Deoxygenated Hb 5031 (450) 4791 (646) − 240.2 (95%CI; 856.5–376.1) 0.42
Oxygenated Hb 18,729 (693) 19,493 (691) 763.8 (95%CI 16.03; 1512) 0.05
Quadrant 2: temporal superior Saturation 2378 (179) 2273 (265) − 104.8 (95%CI 355.9; 146.2) 0.39
Deoxygenated Hb 4946 (474) 4926 (601) − 20.33 (95%CI − 615.0; 574.3) 0.94
Oxygenated Hb 18,464 (810) 19,314 (650) 850.3 (95%CI 69.16; 1631) 0.04
Quadrant 3: temporal inferior Saturation 2317 (176) 2243 (217) − 74.11 (95%CI − 290.8; 142.6) 0.48
Deoxygenated Hb 4722 (327) 4823 (417) 101.0 (95%CI − 311.1; 513.2) 0.61
Oxygenated Hb 18,313 (755) 19,233 (642) 919.9 (95%CI 171.4; 1668) 0.02
Quadrant 4: nasal inferior Saturation 2278 (185) 2267 (293) − 10.86 (95%CI − 283.4; 261.7) 0.93
Deoxygenated Hb 4720 (374) 4825 (610) 104.5 (95%CI − 459.9; 668.8) 0.70
Oxygenated Hb 18,517 (1242) 18,983 (708) 465.9 (95%CI − 586.2; 1518) 0.36
Data are expressed as the mean (SD); means represent relative oxygen density in arbitrary units (AU); significant p values are in italic
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healthy with no observed sickle cell retinopathy. This is also
supported by a previous study which reported a strong corre-
lation between vessel density around the fovea and retinal
thickness, thereby confirming that the eyes of the patients
included in this study were relatively unaffected by SCD [6].
Also, the limited sample size compared with that in previ-
ous studies [6, 18] might be responsible for this observed
difference. Although RFI measurements have been claimed
to be equal and even more detailed compared with OCT-A
[19], the results might also have been distinct due to the use
of different methodologies (fractal analysis versus density
analysis). Furthermore, the inclusion of more peri-foveal re-
gions and choroidal OCT-A measurements might have also
induced more contrast compared with that in our study.
Nevertheless, this methodology was able to observe early ret-
inal changes as expressed by differences in oxygenated Hb.
Our measurements did not show a significant difference
between the SCD group and the matched controls with respect
to saturation measurements. This might be explained by the
fact that the measured differences in endogenous contrast are
probably too small for accurate detection. However, we were
able to observe a significant difference in oxygenated Hb in
the temporal quadrants of sickle cell patients, which is the
location where the disease usually primarily manifests [20].
It is unclear why the superior nasal quadrant also shows sta-
tistical difference. As expected, findings in the nasal quadrant
however showed a smaller difference compared with the find-
ings in the temporal area. The differences in oxygenation
levels more peripheral from the macula might indicate early
retinal damage. Furthermore, in our analysis, we found a low
inter-subject variability, demonstrated by a low SD, which is
in turn reflected by a low MDES. This demonstrates that in
case of clinically relevant changes, they would have been
observed.
The retina is one of the highest energy-demanding tissues
in the body, even surpassing the brain for metabolism, which
leads to a high oxygen consumption [21]. Although decreased
retinal vessel autoregulation has been reported in SCD pa-
tients [22], SCD patients may compensate their lower Hb
and subsequently oxygen-carrying capacity by vascular
autoregulatory mechanisms, such as the dilation of the vessels.
This is demonstrated by higher retinal blood flow, previously
measured in SCD patients [7]. Other techniques have also
demonstrated an increased microvascular flow in other or-
gans, thought to be a compensatorymechanism for the anemia
[23, 24]. The sickle cell patients in this study had an unim-
paired microvasculature around the macula, as demonstrated
by the nCPM measurements. Therefore, the autoregulatory
capacity of the retinal vessels might be sufficient in these
patients, which in turn could lead to normal saturation levels
when compared with those in controls. This theory is also
confirmed in other studies [25]. Interestingly, our study dem-
onstrates that even before microvascular changes are
observed, early retinal changes can already be seen by the
reduced level of oxygenated hemoglobin. This is in line with
findings from other studies in which differences in other or-
gans such as cerebral oximetry have been reported. [26]
This is the first study to quantitatively analyze multispectral
pictures obtained by the RFI, whereas previous studies had only
qualitatively analyzed multispectral pictures [10]. In our current
analysis, we did not compensate for differences in path length,
i.e., absorption and scattering, by the four wavelengths. The
expected difference is negligible as the wavelengths are rela-
tively close to each other. In contrast to other research, we
measured oximetry as an average in the retinal tissue, not in
the individual vessels. This is due to the fact that the current
resolution of the RFI does not allow for the reliable quantifica-
tion in individual vessels using our analysis technology.
A possible limitation of our study is that only females were
included; therefore, we cannot exclude gender effects. However,
since all SCD patients were matched to control subjects, this
does not affect our main conclusions. Although this was an
exploratory study, the limited number of participants caused a
wider confidence interval for most outcomes. However, due to
the low variability and subsequently the low MDES, any clini-
cally relevant contrast would have been picked up. Furthermore,
our measurements were performed around the central macula,
whereas in SCD, retinal abnormalities are usually primarily ob-
served peri-foveal. In this study, nCPM measurements were
performed around the macula, contrary to structural changes
that are usually observed in peripheral areas in SCD.We cannot
exclude that these patients have abnormalities outside the field
of view, more temporal to the fovea. Furthermore, a common
drawback of RFI, opposed to OCT-A, is that it only measures
the retinal vasculature, not the choroidal vasculature. It should
also be noted that the oximetry measurements were still relative,
due to the lack of golden standards for retinal oximetry.
Nevertheless, our study demonstrated that small peri-foveal ab-
normalities expressed as subtle changes in oxygenated Hb can
already be picked up by this methodology.
In summary, our study demonstrated the feasibility of mul-
tispectral imaging to measure retinal changes in oxygenation
in both SCD patients and matched volunteers and that even
before a loss of vascular flow can be detected, a reduced level
of oxygenated hemoglobin might affect retinal function. With
the developed methodology, future studies could be per-
formed in which retinal health is monitored by measuring
changes in retinal oxygenation in diseases such as Central
Retinal Venous Occlusions (CRVO), or retinal detachment.
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